Breaking News, Promotions & Moves

Synta Appoints R&D Prez

Ramachandra brings extensive R&D experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Sumant Ramachandra has been appointed president of R&D at Synta Pharmaceuticals. Dr. Ramachandra joins the company from Hospira, where he led a 1,200-person R&D organization as senior vice president, R&D, Regulatory and Medical Affairs, and chief scientific officer. Prior to joining Hospira in 2008, Dr. Ramachandra served as vice president and oncology portfolio therapeutic area leader at Merck & Co., and therapeutic area head for medical oncology at Pfizer.   “Sumant brings ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters